Dimensional Fund Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Dimensional Fund Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85K	Buy	+13,888	New	+$86.6K	﹤0.01%	3153
2024 Q2	–	Sell	-1,165	Closed	-$69K	–	3415
2024 Q1	$69K	Hold	1,165	–	–	﹤0.01%	3306
2023 Q4	$85.3K	Sell	1,165 -533	-31%	-$21.9K	﹤0.01%	3292
2023 Q3	$65.9K	Buy	1,698 +1	+0.1%	+$51	﹤0.01%	3361
2023 Q2	$97.9K	Hold	1,697	–	–	﹤0.01%	3326
2023 Q1	$110K	Buy	+1,697	New	+$103K	﹤0.01%	3290
2022 Q3	–	Sell	-2,619	Closed	-$50K	–	3528
2022 Q2	$50K	Sell	2,619 -663	-20%	-$33.3K	﹤0.01%	3388
2022 Q1	$266K	Buy	3,282 +1,029	+46%	+$84.8K	﹤0.01%	3269
2021 Q4	$206K	Buy	2,253 +107	+5%	+$12.1K	﹤0.01%	3333
2021 Q3	$268K	Hold	2,146	–	–	﹤0.01%	3300
2021 Q2	$243K	Buy	+2,146	New	+$260K	﹤0.01%	3300

Other funds holding VRCA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors's VRCA Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Verrica Pharmaceuticals (VRCA) in Q2 2026: 13,888 shares worth $85K. The stake represents ﹤0.01% of the portfolio and ranks #3153 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in VRCA as recently as Q1 2024.

Dimensional Fund Advisors first reported a position in VRCA in Q2 2021 and has held it in 11 quarters since. The position peaked at $268K in Q3 2021. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

Dimensional Fund Advisors held 13,888 shares of Verrica Pharmaceuticals worth $85K as of Q2 2026.
Verrica Pharmaceuticals was a new Dimensional Fund Advisors position in Q2 2026.
Verrica Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3153 holding.
Dimensional Fund Advisors first reported a position in Verrica Pharmaceuticals in Q2 2021 and has held it in 11 quarters since.
Dimensional Fund Advisors's Verrica Pharmaceuticals position peaked at $268K in Q3 2021.
43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.